课题基金 / 基金详情

心脏特异性敲除CD38对糖尿病心肌病的保护作用及其机制研究

批准号:
82000354
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
汪玲芳
依托单位:
学科分类:
心肌炎和心肌病
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
汪玲芳

项目摘要

结项摘要

项目成果

汪玲芳的其他基金

相似基金

相关文献

中文摘要
糖脂代谢异常是导致糖尿病心肌病的重要原因,但其分子机制尚未阐明。CD38是哺乳类细胞NAD+的主要降解酶,我们前期发现敲除CD38减轻AngII诱导的心肌肥大及心脏缺血再灌注损伤,并减轻高脂饮食诱导的心脏氧化应激损伤。而CD38对糖尿病心肌病的影响尚未见报道。预实验发现糖尿病小鼠的心脏组织及高糖高脂刺激的心肌细胞CD38表达上调,而Sirt3表达下调,敲除CD38可改善糖尿病小鼠心功能并通过降低细胞凋亡及焦亡减轻心肌细胞损伤。因此,我们提出假说:敲除CD38可激活心肌细胞NAD+/Sirt3信号通路,继而减轻高糖高脂导致的心肌细胞凋亡/焦亡,抑制心肌纤维化从而对糖尿病心肌损伤发挥保护作用。本课题将利用全身及心脏特异性CD38敲除小鼠从整体、细胞、分子水平系统揭示心肌细胞CD38在糖尿病心肌病中的作用及机制,并试图阐明调控CD38转录的分子信号途径,为糖尿病心肌病的防治提供新思路和新靶点。
英文摘要
Abnormal glucose and lipid metabolism is an important cause of the diabetic cardiomyopathy in human being. However, the specific molecular mechanism is still unknown. In mammalian cells, CD38 is a major hydrolase for degradation of NAD+. Our previous studies showed that CD38 knockout mice were resistant to Ang-II induced cardiac hypertrophy and ischemia/reperfusion induced heart injury. In addition, CD38 deficiency could protect heart from high fat diet-induced oxidative stress. However, the roles and mechanisms of CD38 in diabetic cardiomyopathy is not explored. Our preliminary experimental results have shown that the expression of CD38 was up-regulated while the expression of Sirt3 was down-regulated in heart tissue from type 2 diabetic mice and cardiomyocytes stimulated by high glucose and palmitic acid. Moreover, CD38 deficiency improved heart function in diabetic mice and reduced myocardial cell damage by reducing apoptosis and pyroptosis. Therefore, we propose the hypothesis that CD38 deficiency may reduce cardiomyocyte apoptosis/pyroptosis caused by high glucose and high fat and reduce myocardial fibrosis via NAD+/Sirt3 signaling pathway, thereby playing protective roles in diabetic myocardial injury. In this study, the conventional and cardiac-specific CD38 knockout mice will be used to investigate the roles and mechanisms of CD38 in diabetic cardiomyopathy from the animal, cellular and molecular levels. In addition, we will elucidate the upstream signal molecules regulating CD38 transcription, thus providing new targets for the prevention and treatment of diabetic cardiomyopathy clinically.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI: 10.3390/ijms242116008
发表时间: 2023-11-06
期刊: International journal of molecular sciences
影响因子: 5.6
作者: [Wang LF, Li Q, Wen K, Zhao QH, Zhang YT, Zhao JL, Ding Q, Guan XH, Xiao YF, Deng KY, Xin HB]
通讯作者: Xin HB
DOI: 10.1139/cjpp-2022-0454
发表时间: 2023
期刊: Canadian Journal of Physiology and Pharmacology
影响因子:
作者: [Qi Ding, Ke Wen, Qian Li, Qi-Hang Zhao, Jia-Le Zhao, Yun-Fei Xiao, Xiao-Hui Guan, Mei-Xiu Jiang, Feng Zhang, Lingfang Wang]
通讯作者: Lingfang Wang
DOI: 10.3389/fcimb.2021.595575
发表时间: 2021
期刊: Frontiers in Cellular and Infection Microbiology
影响因子: 5.7
作者: [Lingfang Wang, Tingtao Chen, Huan Wang, Xiaoli Wu, Qing Cao, Ke Wen, Ke-Yu Deng, Hongbo Xin]
通讯作者: Hongbo Xin
CD38 Deficiency Protects Mice from High Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Activating NAD(+)/Sirtuins Signaling Pathways-Mediated Inhibition of Lipid Accumulation and Oxidative Stress in Hepatocytes.
CD38 缺陷通过激活 NAD( )/Sirtuins 信号通路介导的肝细胞脂质积累和氧化应激抑制来保护小鼠免受高脂肪饮食诱导的非酒精性脂肪肝病
DOI: 10.7150/ijbs.65588
发表时间: 2021
期刊: International journal of biological sciences
影响因子: 9.2
作者: [Xie L, Wen K, Li Q, Huang CC, Zhao JL, Zhao QH, Xiao YF, Guan XH, Qian YS, Gan L, Wang LF, Deng KY, Xin HB]
通讯作者: Xin HB
SLC1A4介导的丝氨酸转运调控平滑肌细胞表型转化在血管内膜增生中的作用及机制研究
  • 批准号:
    82560089
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32.00万元
  • 批准年份:
    2025
  • 负责人:
    汪玲芳
  • 依托单位:
国内基金
海外基金